Robert Douglas Knight - Apr 5, 2022 Form 4 Insider Report for NexImmune, Inc. (NEXI)

Role
Chief Medical Officer
Signature
/s/ Ilse Johnson, Attorney-in-fact
Stock symbol
NEXI
Transactions as of
Apr 5, 2022
Transactions value $
$0
Form type
4
Date filed
4/7/2022, 07:13 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEXI Stock Options (Right to Buy) Award $0 +48K $0.00 48K Apr 5, 2022 Common Stock 48K $4.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on April 5, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Knight's continued service to the corporation on each vesting date.